Hyperkalaemia management and related costs in chronic kidney disease patients with comorbidities in Spain.
Antonio Olry de Labry LimaÓscar Díaz CastroJorge M Romero-RequenaM de Los Reyes García Díaz-GuerraVirginia Arroyo PinedaM Belén de la Hija DíazMeritxell AscanioJosep DarbàJosep M CruzadoPublished in: Clinical kidney journal (2021)
HK was usually managed by RAASi discontinuation and ion-exchange resin treatment. Most patients with HK were non-adherent to resins and those with severe HK remained with high potassium levels, despite bearing elevated healthcare expenditures.